List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 22 studies with search of: Open Studies | "Acromegaly"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
4 Recruiting Efficacy and Safety of Octreolin for Acromegaly
Condition: Acromegaly
Intervention: Drug: Active oral octreotide study drug therapy
5 Recruiting Study of Heart Effects When Growth Hormone (GH) is Used for Growth Hormone Deficiency (GHD) Following Cure of Acromegaly
Condition: Acromegaly
Intervention: Procedure: echocardiogram
6 Recruiting Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230);   Drug: octreotide LAR 30mg or lanreotide ATG 120mg
7 Recruiting Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
8 Recruiting A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
9 Recruiting Effects of Sandostatin LAR® in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
10 Unknown † Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Condition: Acromegaly
Intervention:
11 Unknown † Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Conditions: Acromegaly;   Type 2 Diabetes Mellitus
Interventions: Other: oral glucose tolerance test;   Other: Subcutaneous administration of recombinant human IGF-1
12 Recruiting Tissue Biomarker for Pegvisomant Action
Condition: Acromegaly
Intervention: Drug: Pegvisomant
13 Recruiting The Observational Study of Growth Hormone-secreting Pituitary Tumors
Conditions: Acromegaly;   Pituitary Tumor
Intervention:
14 Unknown † Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
Conditions: Acromegaly;   Growth Hormone Deficiency
Intervention:
15 Recruiting Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
Condition: Acromegaly
Intervention: Other: Oral Glucose Tolerance Test (OGTT)
16 Unknown † Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
Condition: Acromegaly
Interventions: Drug: Preoperative lanreotide treatment;   Procedure: Transsphenoidal surgery
17 Recruiting Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Conditions: Acromegaly;   Growth Hormone;   Insulin Resistance
Intervention: Procedure: Transsphenoidal adenomectomy
18 Recruiting Genetics of Endocrine Tumours
Condition: Acromegaly
Intervention:
19 Unknown † Estrogen Treatment in Acromegalic Women
Condition: Acromegaly
Intervention: Drug: Alesse
20 Recruiting Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
Condition: Acromegaly
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-22)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services